今日新闻！## 拒不执行人身安全保护令将受严惩！珠海首例家暴男获刑八个月

## 拒不执行人身安全保护令将受严惩！珠海首例家暴男获刑八个月

珠海： 近日，广东省珠海市香洲区人民法院作出一审判决，以拒不执行裁定罪判处被告人张某有期徒刑八个月，这是全国首例因违反人身安全保护令被法院以拒执罪判处刑罚的案件。

案件回顾

被告人张某与被害人小丽曾系夫妻关系，因家庭琐事经常发生争吵，张某多次对小丽实施家庭暴力。2023年10月，小丽不堪忍受，向香洲区人民法院申请人身安全保护令。法院依法审查后，于2023年10月13日作出人身安全保护令，禁止张某对小丽实施殴打、恐吓等家庭暴力行为，禁止张某骚扰、跟踪、接触小丽及女儿。

然而，张某在签收人身安全保护令后，却置若罔闻，于2023年11月、2024年1月多次对小丽实施殴打、恐吓，并向小丽发送大量死亡威胁信息。小丽多次向法院求助，法院依法对张某采取了拘留措施。

法院判决

法院审理认为，张某的行为已构成拒不执行裁定罪。最终，法院依法作出上述判决。

案件意义

• 彰显法律权威。人身安全保护令是法院依法作出的裁定，具有法律约束力。任何个人和组织都应当自觉遵守，不得违反。张某的行为是对法律权威的公然挑衅，理应受到严厉制裁。
• 体现对受害者的关爱。人身安全保护令是保护受害者安全的重要措施。本案的判决表明，司法机关将坚决维护受害者的合法权益，对违反人身安全保护令者依法从严惩处。
• 为维护家庭和谐提供了有力武器。家庭暴力是社会丑恶现象，严重危害家庭和谐。本案的判决对潜在的家庭暴力行为人起到震慑作用，有利于预防和减少家庭暴力的发生。

张某案件的判决，为司法机关依法打击家庭暴力、维护受害者合法权益提供了有益的借鉴。 今后，司法机关将持续加大对家庭暴力的打击力度，形成对家庭暴力的零容忍态势，为建设平安和谐社会贡献司法力量。

## 相关背景

近年来，我国司法机关不断加大对家庭暴力的打击力度，取得了显著成效。2022年8月，最高人民法院出台了《关于办理人身安全保护令案件适用法律若干问题的规定》，进一步完善了人身安全保护令制度。

## 法官说法

香洲区人民法院审判员表示，人身安全保护令是保护受害者安全的重要司法手段，任何个人和组织都应当自觉遵守。对于违反人身安全保护令的行为，司法机关将依法从严惩处，绝不姑息。

## 延伸阅读

• 最高人民法院关于办理人身安全保护令案件适用法律若干问题的规定 [移除了无效网址]
• 广东省珠海市香洲区人民法院关于办理人身安全保护令案件的实施细则 [移除了无效网址]

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.